InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-13.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by ANDREWS DEBORAH J, Director. Officer active across 2 companies, notably Lineage Cell Therapeutics, Inc.. In total, 6 reports have been published. Activity tracked since 29 June 2021. The latest transaction was filed on 15 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
10,466 shares0Common StockSEC:0001325697-26-000006:0
3,755 shares@ US$32.070.0091% mcap66.7% of flowCommon StockSEC:0001325697-26-000006:1
5,233 shares0Common StockSEC:0001325697-26-000006:2
1,877 shares@ US$32.070.0045% mcap33.3% of flowCommon StockSEC:0001325697-26-000006:3
24,720 shares@ US$2.2050.0% of flowCommon Shares, no par valueSEC:0001493152-21-015788
24,720 shares@ US$2.200.011% mcap50.0% of flowCommon Shares, no par valueSEC:0001493152-21-015788:0
6 of 6 declarations
About ANDREWS DEBORAH J
ANDREWS DEBORAH J is a Board Member of Lineage Cell Therapeutics, Inc. She brings expertise in the biotechnology and healthcare sector. As a board member, Deborah plays a key role in the governance of the company and in making strategic decisions. Her experience in the medical field is an asset for innovation and growth at Lineage.
